Hosted on MSN1mon
SurGenTec receives FDA clearance for synthetic bone graft materialHaving undergone almost a decade of research and development, with the FDA clearance, the Florida-based company’s material is recognised as a standalone solution equivalent to autografts ...
Most surgeons diagnose and operate on less than 50 ACL injuries a year. The following results were obtained: 58% (76/132) use bone-patellar tendon-bone autografts, whereas 33% (44/132) use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results